With the developing health and nutrition conditions, the elderly population is increasing in the world and the frequency of diseases and diseases encountered with aging in the society is changing. The most common oncological disease in men with age is Prostate Cancer.
Prostate cancer is one of the most common types of cancer in men and its incidence increases with age.
Since there is no specific complaint for prostate cancer and the disease is usually in advanced stages when the complaint begins, screening all men whether they have a complaint or not is critical for early diagnosis and treatment. Scanning is performed as a standard PSA, Finger Rectal Examination. If prostate cancer is suspected in these scans, advanced diagnostic techniques should be applied.
PSA is critical for the early diagnosis and treatment of prostate cancer. In the evaluation phase, more accurate results can be obtained by using parameters such as the rate of rise of PSA, free / total PSA ratio, PSA according to age, PSA according to prostate volume. In patients with suspected prostate cancer in the screening performed by PSA and Digital Rectal Examination, the next diagnostic step is Prostate Biopsy under the guidance of USG. Prostate biopsy provides a direct tissue diagnosis and can make a treatment or follow-up decision.
Normal values of PSA according to age;
40-49 years 0-2.5
50-59 years 0-3.5
60-69 years 0-4.5
70-79 years 0-6.5
Patients with a family history of prostate cancer have a higher risk of developing prostate cancer at an early age. For this reason, people with a family history of prostate cancer should start the screening program after the age of 40. People without a family history of prostate cancer should apply to a urology specialist once a year for prostate cancer screening after the age of 45.